A major new clinical trial testing whether an early procedure called ablation can improve outcomes for patients living with both heart failure (HF) and atrial fibrillation (AF).
CRAAFT-HF is funded by the British Heart Foundation, sponsored by University College London, and run in partnership with leading NHS hospitals and international collaborators.

Find out more about the study
We use cookies to improve your experience and to help us understand how you use our site. Please refer to our cookie notice and privacy statement for more information regarding cookies and other third-party tracking that may be enabled.
The CRAAFT-HF study is coordinated at Barts Cardiovascular Research Unit (CVCTU) in London and has been reviewed and approved by the Health Research Authority Research Ethics Committee London - Hampstead.
© 2025 CRAAFT-HF